- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 233/45 - Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
Patent holdings for IPC class C07C 233/45
Total number of patents in this class: 13
10-year publication summary
|
0
|
0
|
2
|
0
|
1
|
0
|
2
|
0
|
0
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10174 |
1 |
| Allergan, Inc. | 2155 |
1 |
| Bayer AG | 3560 |
1 |
| Bayer Intellectual Property GmbH | 2353 |
1 |
| Amarin Neuroscience Limited | 1 |
1 |
| Amira Pharmaceuticals, Inc. | 66 |
1 |
| Gavish-galilee Bio Applications Ltd. | 44 |
1 |
| Juno Therapeutics, Inc. | 503 |
1 |
| Nippon Chemical Industrial Co., Ltd. | 294 |
1 |
| Sederma | 263 |
1 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1358 |
1 |
| ATAI Life Sciences AG | 34 |
1 |
| Bsense Bio Therapeutics Ltd. | 3 |
1 |
| Other owners | 0 |